On May 24, 2022 On May 24, 2022, Alaunos Therapeutics, Inc.’s Chief Executive Officer, Kevin S. Boyle Sr., and Vice President of Research & Development, Drew Deniger, Ph.D., presented a presentation at the H.C. Wainwright Global Investment Conference (Presentation, Alaunos Therapeutics, MAY 24, 2022, View Source [SID1234614987]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!